Wednesday May 23, 2018 14:16

Heathcare Press Release : 19 Apr 2018

Swift Biosciences Launches Accel-Amplicon Plus Cancer Panels for Precision Medicine Heathcare—19 Apr 18

- New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus(TM) Cancer